Participants 110 159 3
first-line therapy of metastatic breast carcinoma
Participants 439 524 7
Two hundred twenty-four patients with MBC and no prior therapy for metastatic disease
Participants 1077 1320 3
Patients were removed from study if LVEF declined 20 or more EF units from baseline to a final value of greater than or equal to 50%, or by 10 or more units to a final value of less than 50%, or onset of clinical congestive heart failure (CHF)
Participants 1330 1378 6
Median age was 54 years in both treatment groups
